Ultrasound Guided Fat Fraction (UGFF) enables quantifiable assessment of liver fat during routine ultrasound exams. By providing objective measurements aligned with MR-PDFF, UGFF helps support early detection, risk stratification and ongoing monitoring of patients with chronic liver disease.

Supports reproducible stiffness assessment over time using 2D Shear Wave Elastography, alongside advanced imaging with cSound™ and Continuous Auto-Tissue Optimization (CATO), to help clinicians monitor progression with greater confidence.

Supports ongoing assessment in advanced liver disease using advanced B-Mode imaging, flow evaluation and 2D Shear Wave Elastography, helping clinicians monitor progression and related findings over time.

Supports detection and characterization of suspicious findings using advanced imaging, flow evaluation and contrast-enhanced ultrasound during routine and follow-up exams.

Objective measurements integrated into exams help support consistent assessment and longitudinal monitoring over time.

Reproducible
results

Tools designed to reduce variability help support repeatable exams and greater confidence in follow-up.

High-quality imaging supports confident clinical assessment across a wide range of body types and disease states.

Capabilities help clinicians monitor progression and treatment response with greater consistency.